DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Exelixis, Inc. (EXEL)
« Back to company indexEXEL Chatter Timeline
Stock Ticker for EXEL
Most Active Tweeters for EXEL
| User | Tweets |
|---|---|
| @kevstar044 | 9 |
| @AmericanBanking | 5 |
| @ZolmaxNews | 5 |
| @HealthcareBeat | 4 |
| @TheMarketsDaily | 4 |
Recent Tweets for EXEL
 |
@InsiderAlertsIA $EXEL: New Insider Filing on EXELIXIS, INC.'s Director GEORGE A SCANGOS: https://t.co/Vfj5ONXMfB April 4th 2020, 8:04pm |
 |
@teebizy RT @MelStone31: $EXEL - 04/03 #darkpool prints of size noted afterhours Friday. This one only trades on average 3.69 million shares da… April 4th 2020, 7:04pm |
 |
@MelStone31 $EXEL - 04/03 #darkpool prints of size noted afterhours Friday. This one only trades on average 3.69 million s… https://t.co/UsW9KeaB9k April 4th 2020, 3:04pm |
 |
@StockTexts $EXEL Exelixis, Inc. SEC Filing: Form 4 https://t.co/bjOS0RhgPO April 3rd 2020, 8:04pm |
 |
@HealthcareBeat $3,261.36 of shares sold by Wyszomierski Jack L (Director), reported in a new form 4 filed with the SEC $EXEL https://t.co/QXJcuTTwd3 April 3rd 2020, 8:04pm |
 |
@AlertTrade VOLUME RADAR ALERT: $EXEL Exelixis, Inc ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room April 3rd 2020, 4:04pm |
 |
@dakotafinancial Exelixis, Inc. $EXEL Director Sells $27,090.00 in Stock https://t.co/T1LJpdTjLv April 3rd 2020, 7:04am |
 |
@dvsneden P&L REFLECT DAY 2: - Little gains - STOP OUT $EXEL - Holding a tiny piece of $CDNS https://t.co/A8qjYC1HIa April 3rd 2020, 1:04am |
|
@HealthcareBeat $27,090.00 of shares sold by Scangos George A (Director), reported in a new form 4 filed with the SEC $EXEL https://t.co/wOqk30TyEF April 2nd 2020, 8:04pm |
|
@MonitorAction $EXEL George Scangos Dumps 1.5K Shares of EXELIXIS, INC. https://t.co/sR6kDfarrw April 2nd 2020, 8:04pm |
 |
@fintel_io Insider George A Scangos reports selling 1,500 shares of $EXEL for a total cost of $27,090.00 https://t.co/XL9DPLoxjr April 2nd 2020, 8:04pm |
 |
@WatchlistN Exelixis, Inc. $EXEL Given Average Recommendation of “Buy” by Brokerages https://t.co/gdPCbXCUW1 April 2nd 2020, 5:04am |
 |
@AmericanBanking Exelixis, Inc. $EXEL Given Average Recommendation of “Buy” by Brokerages https://t.co/IUkvqSLX4q #stocks April 2nd 2020, 5:04am |
 |
@ZolmaxNews Exelixis, Inc. $EXEL Given Average Recommendation of “Buy” by Brokerages https://t.co/4R5TxOjkCX April 2nd 2020, 5:04am |
 |
@bret_jensen $IBB $EXEL 2 Covid-19 Proof Biotech Stocks https://t.co/lt1gNDJPUR March 29th 2020, 6:03am |
|
@HealthcareBeat Piper Sandler Reaffirms Buy Rating for Exelixis $EXEL https://t.co/TjWOzuIFnk March 29th 2020, 3:03am |
 |
@stocknewstimes Piper Sandler Reaffirms Buy Rating for Exelixis $EXEL https://t.co/vELJCnvLjj March 29th 2020, 3:03am |
|
@dakotafinancial Exelixis’ $EXEL “Buy” Rating Reaffirmed at Piper Sandler https://t.co/Zr9WFM4CY7 March 29th 2020, 3:03am |
 |
@kevstar044 RT @biotechw2019: $EXEL weekly looks: https://t.co/lgJn59Pgpm March 28th 2020, 11:03am |
 |
@biotechw2019 $EXEL weekly looks: https://t.co/lgJn59Pgpm March 28th 2020, 11:03am |
|
@ZolmaxNews Exelixis $EXEL Trading 9.6% Higher https://t.co/wsZwaAD1MO March 28th 2020, 7:03am |
 |
@TheMarketsDaily Exelixis $EXEL Trading Up 9.6% https://t.co/53ki0oQ58c March 28th 2020, 7:03am |
 |
@ConsumerFeed Piper Sandler Reaffirms “Buy” Rating for Exelixis $EXEL https://t.co/bk7WDjfkN7 March 28th 2020, 4:03am |
|
@ZolmaxNews Exelixis $EXEL Stock Rating Reaffirmed by Piper Sandler https://t.co/Tjey87mSOl March 28th 2020, 3:03am |
|
@TheMarketsDaily Piper Sandler Reaffirms “Buy” Rating for Exelixis $EXEL https://t.co/YrIm8U7XQJ March 28th 2020, 3:03am |
 |
@BlueBioNow $EXEL Hoping to exit this position at some point . . . -2.49 % change recently https://t.co/eWEVF0GCau March 27th 2020, 4:03pm |
|
@kevstar044 $EXEL someone knows something. Looking super strong in the market. @biotechw2019 https://t.co/wW51Scgm2A March 27th 2020, 2:03pm |
 |
@EnterpriseLeade Exelixis, Inc. $EXEL Expected to Announce Earnings of $0.15 Per Share https://t.co/XAthZYdB0f March 27th 2020, 7:03am |
|
@ConsumerFeed Exelixis, Inc. $EXEL Expected to Announce Earnings of $0.15 Per Share https://t.co/65GclUcj0x March 27th 2020, 7:03am |
|
@dakotafinancial Brokerages Anticipate Exelixis, Inc. $EXEL Will Post Earnings of $0.15 Per Share https://t.co/4daKjN5wmk March 27th 2020, 7:03am |
 |
@TranscriptDaily Exelixis, Inc. $EXEL Expected to Announce Earnings of $0.15 Per Share https://t.co/FBXo2VNuRa March 27th 2020, 7:03am |
 |
@dispatchtribune Exelixis $EXEL Rating Reiterated by Piper Sandler https://t.co/fOTNI0SjNn March 27th 2020, 2:03am |
 |
@dailypoliticaln Exelixis $EXEL Rating Reiterated by Piper Sandler https://t.co/bGRUtcCzQB March 27th 2020, 2:03am |
|
@AmericanBanking Piper Sandler Reaffirms “Buy” Rating for Exelixis $EXEL https://t.co/ktOuU0WOiJ #stocks March 26th 2020, 9:03pm |
|
@kevstar044 RT @biotechw2019: $EXEL indecision triangle break down weekly 50-200 week moving avg death crossed https://t.co/pLcR44aymr March 26th 2020, 6:03pm |
|
@kevstar044 $EXEL nice nice action today with massive buying before close. Strong day with an even stronger close. Its brewing.… https://t.co/BpvLHJpkOI March 26th 2020, 4:03pm |
|
@kevstar044 @biotechw2019 I got my good eye on it. $EXEL https://t.co/peu3AP5lya March 26th 2020, 11:03am |
|
@kevstar044 $EXEL @biotechw2019 this time is different. In the green now. Watching closely March 26th 2020, 11:03am |
 |
@StockNewsWires $EXEL: Why Is Exelixis (EXEL) Down 15.6% Since Last Earnings Report?: https://t.co/WRxF85HRyz March 26th 2020, 11:03am |
|
@biotechw2019 $EXEL indecision triangle break down weekly 50-200 week moving avg death crossed https://t.co/pLcR44aymr March 26th 2020, 7:03am |
 |
@WeekHerald Exelixis, Inc. $EXEL EVP Sells $66,367.66 in Stock https://t.co/PcU5uY9LmX March 26th 2020, 6:03am |
|
@ZolmaxNews Exelixis, Inc. $EXEL EVP Sells $66,367.66 in Stock https://t.co/orhBI4tiF6 March 26th 2020, 6:03am |
|
@TheMarketsDaily Exelixis, Inc. $EXEL EVP Patrick J. Haley Sells 4,318 Shares https://t.co/0w5VlXORY4 March 26th 2020, 6:03am |
|
@AmericanBanking Exelixis, Inc. $EXEL Expected to Post Quarterly Sales of $211.45 Million https://t.co/zaweW3twtz #stocks March 26th 2020, 3:03am |
|
@biotechw2019 @kevstar044 $EXEL the hardest part is to figure how much is the news worth ? March 25th 2020, 10:03pm |
|
@kevstar044 RT @ExelixisInc: Our partner @TakedaPharma received approval of $EXEL lead therapy for advanced #kidneycancer in Japan. Read more: https://… March 25th 2020, 9:03pm |
|
@kevstar044 $EXEL huge news out today. Adding more tomorrow. #moneymaker #machine Great long term hold. ?????? @biotechw2019 March 25th 2020, 9:03pm |
 |
@gcassidy718 $EXEL major stock movement -2.49 % change recently https://t.co/yJURATPF4w March 25th 2020, 4:03pm |
 |
@AutonomousCNS $EXEL $TAK - Cabometyx OK'd in Japan for kidney cancer https://t.co/rGBPtBEM8x March 25th 2020, 2:03pm |
 |
@ExelixisInc Our partner @TakedaPharma received approval of $EXEL lead therapy for advanced #kidneycancer in Japan. Read more:… https://t.co/bhKgCBBpby March 25th 2020, 1:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.